Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Treatment
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global HSDDT Market Portraiture
2.2. Global HSDDT Market, by Therapy, 2018 (US$ Mn)
2.3. Global HSDDT Market, by Geography, 2018 (US$ Mn)
Chapter 3. Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global HSDDT Market, by Key Players, 2018
Chapter 4. Global Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market, by Therapy
4.1. Overview
4.2. Buspirone
4.3. Bupropion
4.4. Testosterone
4.5. Flibanserin
4.6. Bremelanotide
4.7. Cognitive Behavior Therapy
4.8. Pipeline Analysis
4.8.1. Phase III Drug
4.8.1.1. Prasterone 6.5 mg Vaginal Insert
4.8.1.2. BP101
Chapter 5. Global Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market, by Geography
5.1. Overview
5.2. North America HSDDT Market Analysis, 2017 – 2027
5.2.1. North America HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
5.2.2. North America HSDDT Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe HSDDT Market Analysis, 2017– 2027
5.3.1. Europe HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
5.3.2. Europe HSDDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific HSDDT Market Analysis, 2017 – 2027
5.4.1. Asia Pacific HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific HSDDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America HSDDT Market Analysis, 2017 – 2027
5.5.1. Latin America HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
5.5.2. Latin America HSDDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa HSDDT Market Analysis, 2017 – 2027
5.6.1. MEA HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
5.6.2. MEA HSDDT Market, by Region, 2017– 2027 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. AMAG Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Allergan, Plc.
6.3. Ivix LLX
6.4. EndoCeutics, Inc.
6.5. Emotional Brain BV
6.6. S1 Biopharma, Inc.
6.7. Sprout Pharmaceuticals, Inc.
List of Figures
FIG. 1 Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market: Research Methodology
FIG. 2 HSDDT: Market Segmentation
FIG. 3 Global HSDDT Market, by Therapy, 2018 (US$ Mn)
FIG. 4 Global HSDDT Market, by Geography, 2018 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2018
FIG. 6 Competitive Analysis: Global HSDDT Market, by Key Players, 2018
FIG. 7 Global Buspirone Market for HSDDT, 2017 – 2027 (US$ Mn)
FIG. 8 Global Bupropion Market for HSDDT, 2017 – 2027 (US$ Mn)
FIG. 9 Global Testosterone Market for HSDDT, 2017 – 2027 (US$ Mn)
FIG. 10 Global Flibanserin Market for HSDDT, 2017– 2027 (US$ Mn)
FIG. 11 Global Bremelanotide Market for HSDDT, 2017 – 2027 (US$ Mn)
FIG. 12 Global Cognitive Behavior Therapy Market for HSDDT, 2017 – 2027 (US$ Mn)
FIG. 13 U.S. HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 14 Canada HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 15 U.K. HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 16 Germany HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 17 Rest of Europe HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 18 China HSDDT Market, 2017– 2027 (US$ Mn)
FIG. 19 Japan HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 20 Rest of Asia Pacific HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 21 Brazil HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 22 Mexico HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 23 Rest of Latin America HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 24 GCC HSDDT Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Middle East and Africa HSDDT Market, 2017 – 2027 (US$ Mn)
List of Tables
TABLE 1 Global Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market Portraiture
TABLE 2 Global HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
TABLE 3 Global HSDDT Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 4 North America HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
TABLE 5 North America HSDDT Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 6 Europe HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
TABLE 7 Europe HSDDT Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 8 Asia Pacific HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
TABLE 9 Asia Pacific HSDDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 10 Latin America HSDDT Market, by Therapy, 2017 – 2027 (US$ Mn)
TABLE 11 Latin America HSDDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 12 Middle East and Africa HSDDT Market, by Therapy, 2017– 2027 (US$ Mn)
TABLE 13 Middle East and Africa HSDDT Market, by Region, 2017 – 2027 (US$ Mn)
TABLE 14 AMAG Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 Allergan, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Ivix LLX: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 EndoCeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Emotional Brain BV: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 S1 Biopharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Sprout Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)